A decreased proportion in CD4 + CD28+ in TCS was observed, but did not reach statistical significance (91.7% (85.4–97.3) vs 98.5% (93.8–99.2) p = 0.07).
← all excerpts
Immunosenescence profile and expression of the aging biomarker (p16<sup>INK4a</sup>) in testicular cancer survivors treated with chemotherapy.
1
0.0700
0.0700